Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY) shares saw an uptick in trading volume on Friday . 6,334 shares traded hands during trading, an increase of 134% from the previous session’s volume of 2,706 shares.The stock last traded at $6.33 and had previously closed at $6.74.

Elekta Price Performance

The company has a 50-day moving average of $6.11 and a 200 day moving average of $5.37. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.79 and a current ratio of 1.04. The firm has a market cap of $2.36 billion, a P/E ratio of 91.44 and a beta of 1.04.

Elekta (OTCMKTS:EKTAY) last posted its quarterly earnings data on Wednesday, November 26th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $427.85 million during the quarter, compared to analysts’ expectations of $436.91 million. Elekta had a net margin of 1.62% and a return on equity of 12.14%. On average, sell-side analysts anticipate that Elekta AB will post 0.36 EPS for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.